you are here: Home News Covovax

Covovax

Current COVID strain mild, SII has produced five to six million Covovax doses, says SII CEO Adar Poonawalla
Adar Poonawalla advises elderly to mask up, take Covovax booster as COVID cases rise
Covid jab Covovax as heterologous booster to be available on CoWIN soon at Rs 225
Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults
Moneycontrol Daily: Your Essential 7
SII seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults
DCGI approves market authorisation for SII's Covid vaccine Covovax as heterologous booster dose
COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla
COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla
Serum Institute seeks drug regulator's approval for market authorisation of its Covid vaccine as booster dose
DCGI panel to review on Friday SII applications for Covovax's use among kids aged 2-7 years, 7-11 years
Covid-19: 10 crore doses of SII's Covovax approved for exports by govt lab, stock rolled out for teens
COVID-19 Vaccination India | Covovax is now available for children aged 12-17 years: Adar Poonawalla
SII's COVID-19 vaccine Covovax now available for 12-17 age group at private centres
Moneycontrol Selects: Top stories this evening
COVID-19 update | NTAGI recommends Covovax for use in 12-17-year-olds in India
For future orders, SII to provide free replacement if vaccine expires: Adar Poonawalla
COVID-19 update | Govt panel recommends inclusion of Covovax in vaccine drive for those aged 12 and above
India's drugs regulator gives nod to phase-3 clinical trial of COVID vaccine Covovax
Serum Institute of India seeks Covovax's inclusion in Covid vaccination drive for 12 years and above
COVID-19 vaccine: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adults
Govt panel recommends EUA for COVID vaccine Covovax for 12-17 age group
Serum Institute seeks EUA for its Covovax vaccine for 12-17 years age group
Govt mulls new vaccines as immunisation drive will likely extend to 12-14-year-olds
Covid-19 booster shot: How safe and effective is the mix-and-match third dose?

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Covovax

Current COVID strain mild, SII has produced five to six million Covovax doses, says SII CEO Adar Poonawalla

Adar Poonawalla advises elderly to mask up, take Covovax booster as COVID cases rise

Covid jab Covovax as heterologous booster to be available on CoWIN soon at Rs 225

Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults

Moneycontrol Daily: Your Essential 7

SII seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults

DCGI approves market authorisation for SII's Covid vaccine Covovax as heterologous booster dose

COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla

COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla

Serum Institute seeks drug regulator's approval for market authorisation of its Covid vaccine as booster dose

DCGI panel to review on Friday SII applications for Covovax's use among kids aged 2-7 years, 7-11 years

Covid-19: 10 crore doses of SII's Covovax approved for exports by govt lab, stock rolled out for teens

COVID-19 Vaccination India | Covovax is now available for children aged 12-17 years: Adar Poonawalla

SII's COVID-19 vaccine Covovax now available for 12-17 age group at private centres

Moneycontrol Selects: Top stories this evening

COVID-19 update | NTAGI recommends Covovax for use in 12-17-year-olds in India

For future orders, SII to provide free replacement if vaccine expires: Adar Poonawalla

COVID-19 update | Govt panel recommends inclusion of Covovax in vaccine drive for those aged 12 and above

India's drugs regulator gives nod to phase-3 clinical trial of COVID vaccine Covovax

Serum Institute of India seeks Covovax's inclusion in Covid vaccination drive for 12 years and above

COVID-19 vaccine: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adults

Govt panel recommends EUA for COVID vaccine Covovax for 12-17 age group

Serum Institute seeks EUA for its Covovax vaccine for 12-17 years age group

Govt mulls new vaccines as immunisation drive will likely extend to 12-14-year-olds

Covid-19 booster shot: How safe and effective is the mix-and-match third dose?